(S)-Alpha-Hydroxy-Beta-methoxy-Beta-phenyl-benzenepropanoic Acid Methyl Ester
CAS: 177036-78-1
Ref. TR-H946295
| 250mg | 85.00 € | ||
| 500mg | 101.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
Product Information
Name:
(S)-Alpha-Hydroxy-Beta-methoxy-Beta-phenyl-benzenepropanoic Acid Methyl Ester
Controlled Product
Synonyms:
- (S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic Acid Methyl Ester
- Ambrisentan Hydroxyester Impurity
- Methyl (2S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoate
- (S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester
- (S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid Methyl Ester (Ambrisentan)
Description:
Impurity Ambrisentan Hydroxyester Impurity
Applications (S)-α-Hydroxy-β-methoxy-β-phenyl-benzenepropanoic Acid Methyl Ester is an impurity in the synthesis of Ambrisentan (A575860), a nonpeptide endothelin ETA receptor antagonist. Antihypertensive. (Ambrisentan Hydroxyester Impurity)
References Riechers, H., et al.: J. Med. Chem., 39, 2123 (1996), Billman, G.E., et al.: Curr. Opin. Invest. Drugs, 3, 1483 (2002), Vatter, H., et al.: Clin. Neuropharmacol., 26, 73 (2003),
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
286.32
Formula:
C17H18O4
Color/Form:
Neat
InChI:
InChI=1S/C17H18O4/c1-20-16(19)15(18)17(21-2,13-9-5-3-6-10-13)14-11-7-4-8-12-14/h3-12,15,18H,1-2H3/t15-/m1/s1
InChI key:
InChIKey=BEPLSLADXOJCBY-OAHLLOKOSA-N
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-H946295 (S)-Alpha-Hydroxy-Beta-methoxy-Beta-phenyl-benzenepropanoic Acid Methyl Ester
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
